Found: 2
Select item for more details and to access through your institution.
Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 388, doi. 10.1111/bjh.17673
- By:
- Publication type:
- Article
Bispecific T cell engager (BiTE<sup>®</sup>) antibody constructs can mediate bystander tumor cell killing.
- Published in:
- PLoS ONE, 2017, v. 12, n. 8, p. 1, doi. 10.1371/journal.pone.0183390
- By:
- Publication type:
- Article